https://openbell.ai/ 2026-09-28T18:52:58.628Z hourly 1.0 https://openbell.ai/support 2026-09-28T18:52:58.628Z monthly 0.7 https://openbell.ai/privacy 2026-09-28T18:52:58.628Z monthly 0.5 https://openbell.ai/terms 2026-09-28T18:52:58.628Z monthly 0.5 https://openbell.ai/feed.json 2026-09-28T18:52:58.628Z hourly 0.8 https://openbell.ai/news/NVDA:1790621114930 2026-09-28T18:45:14.930Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Nvidia-Logo-Displayed-On-A-Smartphone-Sc.jpg?width=250&height=187 Nvidia’s $150B Buyback Has Traders Piling into this ETF Nvidia Corp. (NASDAQ: NVDA) announced a record $150 billion share-repurchase authorization, increasing its buyback capacity to $235 billion, which is expected to be executed through fiscal 2028. Following this announcement, Nvidia's stock rose over 2%, while the GraniteShares 2x Short NVDA Daily ETF (NASDAQ: NVD) saw a decline of about 5%. The trading volume for NVD reached 83.9 million shares on Monday, reflecting heightened investor activity in leveraged ETFs related to Nvidia. https://openbell.ai/news/CIEN:1790620559135 2026-09-28T18:35:59.135Z daily 0.9 https://cdn.brandfetch.io/CIEN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of fiber optic connectivity companies are trading lower. Elevated bond yields and Fed interest rate expectations are weighing on technology sectors that have exposure to AI buildout capex plans that may come under pressure from inflated borrowing costs. openbell Financial News https://openbell.ai/news/STX:1790620318481 2026-09-28T18:31:58.481Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/image.png?width=250&height=187 Seagate Shares Rise Over 6% After Key Trading Signal Seagate Technology Holdings PLC (NASDAQ: STX) saw its shares rise over 6% following a Power Inflow alert, which indicated a significant shift towards buying activity among both retail and institutional investors. The stock was priced at $872.35 when the alert was triggered at 10:47 AM EST, and it reached an intraday high of $928.28 by 2:00 PM EST, marking a gain of 6.41%. This bullish signal emerged after a prior decline in the stock price, highlighting potential for a price reversal. https://openbell.ai/news/KOD:1790620031333 2026-09-28T18:27:11.333Z daily 0.9 https://cdn.brandfetch.io/KOD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Kodiak Sciences, AMC Entertainment, Agenus And Other Big Stocks Moving Higher On Monday Kodiak Sciences Inc (NASDAQ: KOD) saw its shares rise 174% to $88.79 following the release of positive data from its Phase 3 DAYBREAK trial for wet age-related macular degeneration, where both Zenkuda and tabirafusp-ted achieved their primary endpoints. Overall, U.S. stocks were lower on Monday, with the Dow Jones index falling over 200 points. Other notable gainers included AMC Entertainment, which rose 14.5% to $3.36 amid discussions of debt maturity extensions and new revenue streams. https://openbell.ai/news/KOD:1790619957082 2026-09-28T18:25:57.082Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Display-Of-Stock-Market-Quotes.jpg?width=250&height=187 Kodiak Sciences, AMC Entertainment, Agenus And Other Big Stocks Moving Higher On Monday Kodiak Sciences Inc (NASDAQ: KOD) saw its shares surge 174% to $88.79 following the positive results from the Phase 3 DAYBREAK trial for wet age-related macular degeneration, where both Zenkuda and tabirafusp-ted achieved their primary endpoints. Overall, U.S. stocks were lower on Monday, with the Dow Jones index dropping over 200 points. Other notable gainers included AMC Entertainment (NYSE: AMC), which rose 14.5% to $3.36, and Agenus Inc (NASDAQ: AGEN), which increased by 10.1% to $9.40 after receiving a Buy rating from Rodman & Renshaw. https://openbell.ai/news/F:1790619914269 2026-09-28T18:25:14.269Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Sunnyvale--Ca--Usa---Nov-22--2023-A-Ford.jpg?width=250&height=187 Ford Stock Drops Monday: What's Happening? Ford Motor Company (NYSE: F) shares fell 2.28% to $12.43 on Monday, reflecting a broader decline in the automotive sector due to rising crude oil prices and increasing Treasury yields. West Texas Intermediate crude surged 4.2% to approximately $96 per barrel, while the 10-year Treasury yield reached 5.27%, its highest since mid-2007. These factors are expected to increase auto loan rates and impact consumer financing demand, particularly for Ford's high-margin vehicles. https://openbell.ai/news/LFCR:1790619816158 2026-09-28T18:23:36.158Z daily 0.9 https://cdn.brandfetch.io/LFCR/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Downgrades Lifecore Biomedical to Market Perform William Blair analyst Max Smock has downgraded Lifecore Biomedical (NASDAQ: LFCR) from an 'Outperform' rating to 'Market Perform'. This change reflects a shift in the analyst's outlook on the company's performance. https://openbell.ai/news/FUSE:1790619586998 2026-09-28T18:19:46.998Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Stock-Graph-With-Green-Candle-Spike.jpg?width=250&height=187 Why Is Fusemachines Stock Gaining Monday? Fusemachines Inc. (NASDAQ: FUSE) stock rose over 17% on Monday following the announcement of an infrastructure update for its AI Twin technology, supported by IBM Fusion infrastructure. The stock significantly outperformed the broader market, with the Nasdaq down 0.86% and the S&P 500 down 0.54%. Trading volume reached 50.40 million shares, far exceeding the 100-day average of 1.40 million shares, indicating heightened market activity. The company also recently secured a $10.66 million investment from Meteora Capital to further its Agentic AI platform and product innovation. https://openbell.ai/news/REDL:1790619555806 2026-09-28T18:19:15.806Z daily 0.9 https://cdn.brandfetch.io/REDL/w/400/h/400?c=1idopYfmtR7ZKg8QMud REDLattice To Go Public Via Bold Eagle SPAC Merger At $1.25B Pre-Money Enterprise Value, Under Ticker "REDL" Around Year-End 2026 REDLattice is set to go public through a merger with Bold Eagle Acquisition Corp., valuing the company at a pre-money enterprise value of $1.25 billion. The transaction includes $335 million of committed capital, with a $60 million investment led by AE Industrial and Eagle Equity Partners. For the twelve months ending June 30, 2026, REDLattice reported $267 million in revenue, reflecting a 29% year-over-year growth, and has a contracted backlog of $200 million with an active pipeline of $1.5 billion. https://openbell.ai/news/CVX:1790619400007 2026-09-28T18:16:40.007Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Night-View-Chevron-Sign.jpg?width=250&height=187 Strong Refining Will Drive Chevron, ExxonMobil Q3 Results: Analyst TD Cowen analyst Jason Gabelman raised price forecasts for Chevron Corporation from $205 to $215 and for ExxonMobil Holdings from $168 to $180, maintaining a Hold rating for Chevron and a Buy rating for ExxonMobil. Chevron is expected to generate about $1 billion in free cash flow with its Venezuela expansion, while ExxonMobil's third-quarter results are anticipated to beat consensus due to strong refining performance despite a $2 billion timing headwind. Chevron shares rose 1.07% to $206.64 and ExxonMobil shares increased 1.03% to $162.25 at the time of publication. https://openbell.ai/news/ZS:1790619167375 2026-09-28T18:12:47.375Z daily 0.9 https://cdn.brandfetch.io/ZS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Zscaler shares are trading higher after Wedbush reiterated its Outperform rating on the stock and maintained its $215 price target. openbell Financial News https://openbell.ai/news/NVDA:1790619044064 2026-09-28T18:10:44.064Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Jim-Cramer.png?width=250&height=187 Nvidia Stock Gains on Record Buyback: Jim Cramer Gets His Wish Nvidia Corp (NASDAQ: NVDA) announced a record stock buyback, increasing its total authorization to $235 billion, the largest in history. This decision comes amid potential pressure on future earnings and revenue forecasts, with the buyback set to be executed through fiscal 2028. Following the announcement, Nvidia's stock rose 2.3% to $230.28, reflecting a year-to-date increase of 21.9%. The move aligns with CNBC host Jim Cramer's earlier suggestion for a significant buyback to boost investor confidence. https://openbell.ai/news/MBAI:1790618678240 2026-09-28T18:04:38.240Z daily 0.9 https://cdn.brandfetch.io/MBAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Northland Capital Markets Initiates Coverage On MBody AI with Outperform Rating, Announces Price Target of $10 Northland Capital Markets has initiated coverage on MBody AI (NASDAQ: MBAI) with an Outperform rating. The firm has set a price target of $10 for the company's stock. https://openbell.ai/news/KNRX:1790618572255 2026-09-28T18:02:52.255Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Tallinn--Estonia---August-4th-2023---Scr.jpg?width=250&height=187 Dow Dips Over 200 Points; Dallas Fed’s Manufacturing Index Declines In September U.S. stocks experienced a decline, with the Dow Jones falling over 200 points to 51,611.16, a 0.42% drop. The Dallas Fed's manufacturing index for Texas decreased to 9.8 in September from 11.6 in August. Notable stock movements included Knorex Ltd, which surged 298% to $1.23 following a strategic carve-out announcement, and Kodiak Sciences Inc, which rose 177% to $89.52 after meeting primary endpoints in a clinical study. https://openbell.ai/news/VRTX:1790618449736 2026-09-28T18:00:49.736Z daily 0.9 https://cdn.brandfetch.io/VRTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $615 UBS analyst Michael Yee has reaffirmed a Buy rating on Vertex Pharmaceuticals (NASDAQ: VRTX) and increased the price target from $585 to $615. This adjustment reflects a positive outlook for the company's performance in the market. https://openbell.ai/news/ETN:1790618405525 2026-09-28T18:00:05.525Z daily 0.9 https://cdn.brandfetch.io/ETN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of data center infrastructure-related companies are trading lower. Elevated bond yields and Fed interest rate expectations are weighing on technology sectors that have exposure to AI buildout capex plans that may come under closer scrutiny from inflated borrowing costs. openbell Financial News https://openbell.ai/news/USO:1790618202776 2026-09-28T17:56:42.776Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'White House weighs red-dyed diesel tax relief to lower fuel prices' - Reuters The White House is considering tax relief on red-dyed diesel fuel as a measure to reduce fuel prices. This potential policy change aims to alleviate the financial burden on consumers and businesses facing rising fuel costs. The move could have significant implications for the market, particularly affecting companies reliant on diesel fuel. https://openbell.ai/news/CRON:1790618152812 2026-09-28T17:55:52.812Z daily 0.9 https://cdn.brandfetch.io/CRON/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Securities Maintains Buy on Cronos Group, Raises Price Target to C$7 TD Securities analyst Derek Lessard has maintained a Buy rating on Cronos Group (TSX: CRON) and raised the price target from C$6 to C$7. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/MDB:1790618126144 2026-09-28T17:55:26.144Z daily 0.9 https://cdn.brandfetch.io/MDB/w/400/h/400?c=1idopYfmtR7ZKg8QMud MongoDB shares are trading lower. The company announced its CEO Chirantan Desai has stepped down effective immediately to pursue a senior role at Meta Platforms. openbell Financial News https://openbell.ai/news/VRT:1790618094008 2026-09-28T17:54:54.008Z daily 0.9 https://cdn.brandfetch.io/VRT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of data center infrastructure-related companies are trading lower. Elevated bond yields and Fed interest rate expectations are weighing on technology sectors that have exposure to AI buildout capex plans that may come under closer scrutiny from inflated borrowing costs. openbell Financial News https://openbell.ai/news/KNRX:1790617936775 2026-09-28T17:52:16.775Z daily 0.9 https://cdn.brandfetch.io/KNRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud KNOREX Pursues Strategic Carve-Out Of AscendX Media Technologies Subsidiary; AscendX Would Be Separated And Independently Capitalized With Investment From External Investors, And KNOREX Expects To Retain A Minority Equity Interest In AscendX KNOREX Ltd. is pursuing a strategic carve-out of its wholly owned subsidiary, AscendX Media Technologies, which focuses on publisher monetization. The proposed structure aims to separate AscendX and allow it to be independently capitalized through external investments, while KNOREX plans to retain a minority equity interest. This move is expected to relieve KNOREX from funding AscendX's future growth, enabling the company to focus on its KNOREX XPO™ platform and other strategic initiatives. https://openbell.ai/news/SMCI:1790617934603 2026-09-28T17:52:14.603Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Super-Micro-Computer--Inc.jpg?width=250&height=187 What's Going On With Super Micro Computer Stock Monday? Super Micro Computer, Inc. (NASDAQ: SMCI) saw its stock decline by nearly 3% on Monday, trading at $42.08, amid broader market pressures including a 0.87% drop in the Nasdaq and rising oil prices. The decline is attributed to a risk-off sentiment among investors, as the 10-year Treasury yield reached its highest level since 2007. Despite the drop, SMCI remains above its key moving averages and has a Hold consensus rating with an average price forecast of $39.50 from analysts. https://openbell.ai/news/MU:1790617858107 2026-09-28T17:50:58.107Z daily 0.9 https://cdn.brandfetch.io/MU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of memory and storage-related companies are trading lower. Elevated bond yields and Fed interest rate expectations are weighing on technology sectors that have exposure to AI buildout capex plans that may come under closer scrutiny from inflated borrowing costs. openbell Financial News https://openbell.ai/news/NTES:1790617779588 2026-09-28T17:49:39.588Z daily 0.9 https://cdn.brandfetch.io/NTES/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Reiterates Overweight on NetEase, Maintains $163 Price Target Morgan Stanley analyst Yang Liu has reiterated an Overweight rating on NetEase (NASDAQ: NTES) and maintained a price target of $163 for the stock. This endorsement suggests a positive outlook for NetEase in the market. https://openbell.ai/news/SPY:1790617678277 2026-09-28T17:47:58.277Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Wall-Street-And-New-Street--New-York--Us.jpg?width=250&height=187 $700 Billion S&P 500 Sell-Off Meets $100 Oil: Are Investors Rotating Into Value ETFs? On Monday, the S&P 500 experienced a significant sell-off, erasing nearly $700 billion in market capitalization as U.S. Treasury yields reached multi-year highs and oil prices approached $100 per barrel. The Nasdaq 100 fell 1.6%, while Brent crude rose 4% to $108.50, marking a 20% increase for September. The market is currently assessing whether this decline indicates a shift from growth-oriented investments to value-focused ETFs, particularly in sectors like energy and defensives, as the equal-weight S&P 500 also showed a 4% drop for the month. https://openbell.ai/news/MCD:1790617623886 2026-09-28T17:47:03.886Z daily 0.9 https://cdn.brandfetch.io/MCD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Melius Research Maintains Sell on McDonald's, Lowers Price Target to $230 Melius Research analyst Jacob Aiken Phillips has maintained a 'Sell' rating on McDonald's (NYSE: MCD) and reduced the price target from $250 to $230. https://openbell.ai/news/PEP:1790617622643 2026-09-28T17:47:02.643Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Pepsi.jpg?width=250&height=187 This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday Deutsche Bank analyst Steve Powers downgraded PepsiCo Inc (NASDAQ: PEP) from Buy to Hold and reduced the price target from $155 to $138, while PepsiCo's stock closed at $128.63 on Friday. This downgrade is part of a broader trend, as several companies, including RLJ Lodging Trust and Braskem SA, also experienced downgrades from various analysts. The changes reflect a cautious outlook on these stocks amid market conditions. https://openbell.ai/news/OKTA:1790617537192 2026-09-28T17:45:37.192Z daily 0.9 https://cdn.brandfetch.io/OKTA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Scotiabank Maintains Sector Outperform on Okta, Raises Price Target to $245 Scotiabank analyst Patrick Colville has reaffirmed a Sector Outperform rating for Okta (NASDAQ: OKTA) and increased the price target from $190 to $245. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/OKTA:1790617448590 2026-09-28T17:44:08.590Z daily 0.9 https://cdn.brandfetch.io/OKTA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Okta shares are trading higher after Citizens maintained the stock with a Market Outperform rating and raised the price target from $180 to $225. openbell Financial News https://openbell.ai/news/BSX:1790617447572 2026-09-28T17:44:07.572Z daily 0.9 https://cdn.brandfetch.io/BSX/w/400/h/400?c=1idopYfmtR7ZKg8QMud FDA Flags Boston Scientific Catheter Recall Boston Scientific Corp (NYSE: BSX) is recalling all Imager II Angiographic Catheters due to a manufacturing defect that compromises patient safety, specifically a flaw in the catheter tip. The company has advised customers to immediately remove these products from inventory and is permanently discontinuing the product line. As of July 16, there have been two serious injuries linked to this issue, although no deaths have been reported. Following the announcement, Boston Scientific's shares fell 0.25% to $43.81, nearing its 52-week low of $42.20. https://openbell.ai/news/COIN:1790617439159 2026-09-28T17:43:59.159Z daily 0.9 https://cdn.brandfetch.io/COIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Keefe, Bruyette & Woods Reinstates Outperform on Coinbase Global, Announces $237 Price Target Keefe, Bruyette & Woods analyst Stephen Glagola has reinstated an 'Outperform' rating on Coinbase Global (NASDAQ: COIN) and set a price target of $237 for the stock. https://openbell.ai/news/BSX:1790617439023 2026-09-28T17:43:59.023Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Motala--Sweden--7-January-2023-Fda-Logo-.jpg?width=250&height=187 FDA Flags Boston Scientific Catheter Recall Boston Scientific Corp (NYSE: BSX) is recalling all Imager II Angiographic Catheters due to a manufacturing defect that compromises patient safety, specifically related to the catheter tip. The company has advised customers to immediately remove these products from inventory and has permanently discontinued the product line. As of July 16, there have been two serious injuries linked to this issue, although no deaths have been reported. Following the announcement, Boston Scientific shares fell 0.25% to $43.81, nearing its 52-week low of $42.20. https://openbell.ai/news/BSX:1790617376955 2026-09-28T17:42:56.955Z daily 0.9 https://cdn.brandfetch.io/BSX/w/400/h/400?c=1idopYfmtR7ZKg8QMud FDA Flags Boston Scientific Catheter Recall The FDA has announced a recall of all Imager II Angiographic Catheters from Boston Scientific Corp (NYSE: BSX) due to a manufacturing defect that compromises patient safety. The defect involves inadequate stabilizing agents in the catheter tip, which could lead to detachment during medical procedures, posing severe health risks. As of July 16, there have been two serious injuries reported linked to this issue, though no deaths. Following the recall announcement, Boston Scientific shares fell 0.25% to $43.81, nearing their 52-week low of $42.20. https://openbell.ai/news/ABBV:1790617114898 2026-09-28T17:38:34.898Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Dementia-In-Senior-People--Memory-Loss--.jpg?width=250&height=187 AbbVie’s New Parkinson’s Pill Could Become a Billion-Dollar Drug, Analyst Says AbbVie Inc. received FDA approval for its new Parkinson's medication, Juvmo (tavapadon), which is the first selective D1/D5 receptor agonist for adults with Parkinson's disease. The drug is expected to be available in the U.S. by October 2026, with an estimated list price of $4,900 for a 30-day supply. Analysts project Juvmo could generate $1.4 billion in sales by 2040, contributing to AbbVie's overall Parkinson's franchise, which is anticipated to reach at least $5 billion in peak sales. AbbVie shares rose 1.03% to $263.70, nearing a 52-week high. https://openbell.ai/news/LLY:1790617071522 2026-09-28T17:37:51.522Z daily 0.9 https://cdn.brandfetch.io/LLY/w/400/h/400?c=1idopYfmtR7ZKg8QMud "Lilly CEO Eyes Bigger Deals in Hunt for Pharma’s ‘White Spaces’" - Bloomberg News Eli Lilly's CEO has expressed intentions to pursue larger acquisitions to explore untapped opportunities in the pharmaceutical sector, referred to as 'white spaces.' The company is focusing on expanding its portfolio through strategic deals to enhance growth. This approach aligns with Lilly's ongoing efforts to innovate and strengthen its market position. https://openbell.ai/news/META:1790616641556 2026-09-28T17:30:41.556Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Ljubljana--Slovenia---21-January-2023-Me.jpg?width=250&height=187 Meta Is Coming for Europe’s Bond Market: AI Debt Is Going Global Meta Platforms Inc (NASDAQ: META) is set to enter Europe's bond market for the first time this autumn as it seeks funding for its AI initiatives, marking a shift from U.S.-centric borrowing to a global approach. This move aligns with a trend among U.S. hyperscalers, who are increasingly tapping into euro-denominated debt, with such companies accounting for nearly 10% of new euro bond issuances. The European Central Bank estimates that hyperscalers may require over $1 trillion in capital expenditures by 2028, highlighting the growing need for diverse funding sources. https://openbell.ai/news/IONQ:1790616609592 2026-09-28T17:30:09.592Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Central-Processing-Unit-cpu-With-Circuit.jpg?width=250&height=187 IonQ Stock Wins Analyst Backing Ahead of 2027 Superion Launch IonQ Inc. (NYSE: IONQ) received a Buy rating from BofA Securities, with a price target of $60, citing its semiconductor-based design as a pathway to scalable quantum computing. The company's stock has been volatile, currently trading at $47.15, approximately 44% below its 52-week high of $84.64. IonQ's Superion 256 system, set for customer deliveries in Q2 2027, is expected to feature 256 physical qubits and aims for over 80,000 logical qubits by 2030. BofA forecasts sales growth from $130 million in 2025 to $3.7 billion by 2030, reflecting a 69% compound annual growth rate from 2026 to 2030. https://openbell.ai/news/KOD:1790616500693 2026-09-28T17:28:20.693Z daily 0.9 https://cdn.brandfetch.io/KOD/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Buy on Kodiak Sciences, Raises Price Target to $120 UBS analyst Michael Yee has maintained a Buy rating on Kodiak Sciences (NASDAQ: KOD) and raised the price target from $80 to $120. This adjustment reflects positive sentiment regarding the company's performance and potential growth. https://openbell.ai/news/ROC:1790616480218 2026-09-28T17:28:00.218Z daily 0.9 https://cdn.brandfetch.io/ROC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Craig-Hallum Initiates Coverage On Rank One Computing with Buy Rating, Announces Price Target of $6.5 Craig-Hallum analyst Jeff Van Sinderen has initiated coverage on Rank One Computing (NASDAQ: ROC) with a Buy rating. The firm has set a price target of $6.50 for the stock. https://openbell.ai/news/MRVL:1790616300837 2026-09-28T17:25:00.837Z daily 0.9 https://cdn.brandfetch.io/MRVL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching Marvell Technology; Hearing Zacks Tech Innovators Buys Stock openbell Financial News https://openbell.ai/news/PANW:1790616106845 2026-09-28T17:21:46.845Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Palo-Alto-Networks-Logo-And-Sign-At-Sili.jpg?width=250&height=187 Palo Alto’s AI Security Trio Could Fuel a Growth Surge, BTIG Says Palo Alto Networks Inc (NASDAQ: PANW) is expected to see significant revenue growth, with pro forma revenue projected to increase over 17% this year, surpassing the Street's expectation of 14.6%. Analyst Gray Powell raised the price target from $404 to $425, highlighting key products like Chronosphere, which has crossed $500 million in ARR and could exceed $800 million by FY27, and Prisma AIRS, expected to grow from $120 million to over $400 million in ARR by the end of FY27. Shares rose by 3.89% to $389.32 following the positive outlook. https://openbell.ai/news/BP:1790616015002 2026-09-28T17:20:15.002Z daily 0.9 https://cdn.brandfetch.io/BP/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'BP Is Said to Weigh Sale of Its Brazilian Biofuels Business' - Bloomberg News BP is reportedly considering the sale of its Brazilian biofuels business as part of a strategic review. This potential divestiture aligns with BP's broader efforts to streamline operations and focus on core areas. The decision comes amid ongoing shifts in the biofuels market and BP's commitment to transitioning towards renewable energy sources. https://openbell.ai/news/MU:1790615658934 2026-09-28T17:14:18.934Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Micron-Logo-Displayed-On-A-Smartphone-Sc.jpg?width=250&height=187 Micron Heads Into Earnings as JPMorgan Sees HBM Shortage Lasting Through 2028 JPMorgan analyst Harlan Sur anticipates that Micron Technology Inc. (NASDAQ: MU) will report strong memory pricing in its upcoming fourth-quarter earnings, with expectations for August-quarter revenue, gross margin, and EPS to exceed Wall Street estimates of $51.4 billion, 86.2%, and $31.73, respectively. Sur projects that DRAM and NAND prices will rise over 20% sequentially, and Micron's data-center business is expected to surpass a $100 billion annualized revenue run rate. Additionally, Sur forecasts that HBM shortages will persist through 2028, maintaining upward pressure on pricing, while Micron plans to return excess cash via share buybacks following its CHIPS Act deal anniversary. As of the report, Micron's stock was down 3.89% at $1040.18. https://openbell.ai/news/USO:1790615628198 2026-09-28T17:13:48.198Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Oil is trading higher following reports suggesting President Trump rejected Iran's plan to reopen the Strait of Hormuz and that he may resume strikes on the country after the midterm election. Also, President Trump is weighing a diesel export ban, which would contribute to ongoing global supply constraints. openbell Financial News https://openbell.ai/news/MBD:1790615501114 2026-09-28T17:11:41.114Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Benzinga-Quick-Spark.jpg?width=250&height=187 QUICK SPARK: MongoDB Stock Craters 18% after CEO Departure to Meta MongoDB Inc. (NASDAQ: MBD) shares fell by 18.5% following the unexpected resignation of CEO Chirantan Desai, who is joining Meta Platforms. Dev Ittycheria, the former CEO, has returned as interim president and CEO. Despite this leadership change, MongoDB maintained its guidance for the third quarter with adjusted EPS projected at $1.57-$1.61, exceeding the $1.54 consensus, and fiscal 2027 EPS expected at $6.39-$6.58, above the $6.13 estimate. https://openbell.ai/news/KNRX:1790615164291 2026-09-28T17:06:04.291Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Communication Services Stocks Moving In Monday's Intraday Session On Monday, Knorex (AMEX: KNRX) saw a significant increase of 301.3%, reaching $1.22, with a market value of $9.2 million. Other notable gainers included Intelligent Group (NASDAQ: INTJ) which rose 21.48% to $3.28, and Able View Global (NASDAQ: ABLV) which increased by 19.23% to $1.55. Conversely, TEN Hldgs (NASDAQ: XHLD) experienced a sharp decline of 92.7%, falling to $0.94, while Treasure Global (NASDAQ: TGL) dropped 30.52% to $1.48. https://openbell.ai/news/KOD:1790615164094 2026-09-28T17:06:04.094Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Health Care Stocks Moving In Monday's Intraday Session On Monday, Kodiak Sciences (NASDAQ: KOD) saw its shares surge by 172.3% to $88.08, bringing its market value to $2.0 billion. Other notable gainers included Accuray (NASDAQ: ARAY) with a 58.27% increase to $0.34 and Lifecore Biomedical (NASDAQ: LFCR) which rose by 55.98% to $6.55. Conversely, MediciNova (NASDAQ: MNOV) experienced a significant decline of 32.0%, dropping to $1.75, while NewGenIvf Group (NASDAQ: NIVF) fell by 30.43% to $0.39. https://openbell.ai/news/SOAR:1790615163833 2026-09-28T17:06:03.833Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Industrials Stocks Moving In Monday's Intraday Session On Monday, Volato Group (AMEX: SOAR) shares surged by 133.1% to $0.42, with a market cap of $9.6 million. Other notable gainers included Enigmatig (AMEX: EGG), which rose 44.64% to $4.05, and Mint (NASDAQ: MIMI), increasing by 22.17% to $0.94. Conversely, Masonglory (NASDAQ: MSGY) experienced the largest decline, dropping 57.9% to $3.4, while Green Circle Decarbonize (AMEX: GCDT) fell 21.54% to $0.53. https://openbell.ai/news/CLRO:1790615163632 2026-09-28T17:06:03.632Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Information Technology Stocks Moving In Monday's Intraday Session On Monday, ClearOne (NASDAQ: CLRO) saw its stock price surge by 44.5% to $4.98, with a market capitalization of $9.2 million. Other notable gainers included MagnaChip Semiconductor (NYSE: MX), which rose 19.39% to $3.94, and Cango (NYSE: CANG), up 17.27% to $2.24. Conversely, Gen Digital Inc. (NASDAQ: GENVR) experienced a significant decline, with its stock falling 20.9% to $0.87, while MongoDB (NASDAQ: MDB) dropped 17.63% to $338.09, maintaining a market value of $33.0 billion. https://openbell.ai/news/ZYME:1790615155146 2026-09-28T17:05:55.146Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Merger-And-Acquisition-Business-Corporat.jpg?width=250&height=187 Zymeworks Updates Annual Financial Targets After Finalizing Theravance Biopharma Deal Zymeworks Inc. has finalized its acquisition of Theravance Biopharma and updated its financial guidance for fiscal year 2026, projecting revenue between $278 million and $292 million and adjusted EBITDA of $114 million to $128 million. The acquisition adds YUPELRI to Zymeworks' portfolio, which generated $133.1 million in sales in the first half of 2026, and the company expects a mid-teens internal rate of return from this deal. Zymeworks shares rose 2.34% to $27.14 following the announcement.